Amyloid-beta plaques — Drug Target

All drugs that target Amyloid-beta plaques — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

PET imaging agent · PET imaging agent / amyloid tracer

Marketed (1)

• Neuraceq (florbetaben 18F) · Piramal Imaging Limited · PET imaging agent · Neurology / Diagnostic Imaging
  Florbetaben 18F is a positron emission tomography (PET) imaging agent that binds to amyloid-beta plaques in the brain to detect Alzheimer's disease pathology.

Phase 3 pipeline (1)

• Florbetaben (BAY94-9172) · Life Molecular Imaging SA · PET imaging agent / amyloid tracer · Neurology / Diagnostic Imaging
  Florbetaben is a fluorine-18 labeled imaging agent that binds to amyloid-beta plaques in the brain for positron emission tomography (PET) detection.